Amoy Diagnostics: Announcement regarding the progress of share repurchase.
Amoy Diagnostics: Announcement on cooperative diagnosis cooperation with Siemens Healthineers.
Amoy Diagnostics: Announcement on the company obtaining registration certificate for medical instruments.
Amoy Diagnostics: Notice regarding the disclosure of the abbreviated equity change report.
Amoy Diagnostics: Simplified Equity Change Report
Amoy Diagnostics: Announcement on the progress of share repurchases
Amoy Diagnostics: Announcement on the implementation of the distribution of rights in 2023
Amoy Diagnostics: Announcement on reaching an accompanying diagnosis cooperation with Boehringer Ingelheim
Amoy Diagnostics: 300685 Ed Biotech Investor Relations Management Information 20240516
Amoy Diagnostics: Announcement on the completion of partial restricted stock repurchases and cancellations
Amoy Diagnostics: Ed Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Amoy Diagnostics: 2023 Annual General Meeting of Shareholders Legal Opinions
Amoy Diagnostics: Announcement on the repurchase and cancellation of some restricted shares in the 2023 Restricted Stock Incentive Plan
Amoy Diagnostics: Announcement of Resolutions of the 18th Meeting of the Third Board of Supervisors
Amoy Diagnostics: Legal opinion on matters relating to the repurchase and cancellation of some restricted stocks in the 2023 Restricted Stock Incentive Plan of Xiamen Aide Biomedical Technology Co., Ltd.
Amoy Diagnostics: Announcement of Resolutions of the 19th Meeting of the Third Board of Directors
Amoy Diagnostics: Notice to creditors on capital reduction notice for repurchase and cancellation of some restricted shares
Amoy Diagnostics: Announcement on holding the 2023 Online Results Briefing and Participating in the Online Group Reception Day for Investors of Listed Companies in the Xiamen Area
Amoy Diagnostics: Announcement on the progress of share repurchases
Ed Biotech: Report for the first quarter of 2024
No Data